Volume 41 – Number 1

>

Editorial

>

Prevalence of cardiovascular risk factors, target organ damage, and subclinical and symptomatic cardiovascular disease in a national population of patients with chronic myeloid leukemia

>

Stroke, systemic embolism, and major bleeding in patients with venous thromboembolism during Vitamin K antagonist treatment. Results from the EVENT HO study

>

Association of matrix metalloproteinases with poor prognosis in hospitalized patients with COVID-19

>

Clinical application of molecular diagnostics in myeloid disorders: recommendations for implementing a common strategy in Spanish centers

>

Journal of a transfusion center in times of COVID-19